Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic GI Cancers”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableWithdrawnNCT02477657
What this trial is testing

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

Who this might be right for
Refractory Malignant Ascites
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT01434069
What this trial is testing

Phase I Trial of Combination of FOLFIRI and SOM 230

Who this might be right for
Gastrointestinal Tumor
H. Lee Moffitt Cancer Center and Research Institute 16
Testing effectiveness (Phase 2)UnknownNCT02595320
What this trial is testing

Capecitabine in Metastatic Breast and GI Cancers

Who this might be right for
Breast CancerGastrointestinal Cancer
Qamar Khan 200
Testing effectiveness (Phase 2)Ended earlyNCT03628079
What this trial is testing

A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.

Who this might be right for
Cancer of the Gastrointestinal TractCancer of Unknown Origin
Repos Pharma 11
Testing effectiveness (Phase 2)Study completedNCT00460603
What this trial is testing

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Pfizer 187
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06427798
What this trial is testing

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Who this might be right for
Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT01862003
What this trial is testing

Phase I/II Trial of Antagonism of HER in GI Cancer

Who this might be right for
Metastatic Colorectal CancerRecurrent Colorectal Cancer
University College, London 24
Early research (Phase 1)Ended earlyNCT00300027
What this trial is testing

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Who this might be right for
Gastrointestinal Neoplasms
Bristol-Myers Squibb 50
Early research (Phase 1)Looking for participantsNCT06414733
What this trial is testing

HER-2 B Cell Peptide Vaccine

Who this might be right for
Metastatic Breast CancerHER2-positive Breast CancerEGFR Overexpression+2 more
Pravin T.P Kaumaya 42
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Not applicableLooking for participantsNCT04782557
What this trial is testing

EUS Guided HVA and PVA for Circulating Tumor DNA in Patients

Who this might be right for
Circulating Tumor CellGastrointestinal Cancer
Chinese University of Hong Kong 60
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableLooking for participantsNCT07483658
What this trial is testing

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Who this might be right for
Reccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate Cancer+3 more
CHU de Quebec-Universite Laval 434
Testing effectiveness (Phase 2)Ended earlyNCT01648465
What this trial is testing

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Who this might be right for
Gastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine Tumors+1 more
Hellenic Cooperative Oncology Group 25
Testing effectiveness (Phase 2)Study completedNCT02279602
What this trial is testing

Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 7
Testing effectiveness (Phase 2)Looking for participantsNCT06922383
What this trial is testing

A Clinical Study of Arfolitixorin in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Isofol Medical AB 90
Early research (Phase 1)Ended earlyNCT04729205
What this trial is testing

Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies

Who this might be right for
CancerGastro-Intestinal Intraepithelial Neoplasia
Lipomedix Pharmaceuticals Inc. 9
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Next Page